Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.

Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC.

Biomaterials. 2019 Jul;208:83-97. doi: 10.1016/j.biomaterials.2019.04.005. Epub 2019 Apr 8.

PMID:
30999154
2.

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer.

Sikander M, Malik S, Chauhan N, Khan P, Kumari S, Kashyap VK, Khan S, Ganju A, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC.

Cancers (Basel). 2019 Mar 14;11(3). pii: E364. doi: 10.3390/cancers11030364.

3.

Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.

Ganju A, Chauhan SC, Hafeez BB, Doxtater K, Tripathi MK, Zafar N, Yallapu MM, Kumar R, Jaggi M.

Br J Cancer. 2018 Feb 20;118(4):587-599. doi: 10.1038/bjc.2017.431. Epub 2018 Feb 20.

4.

Quantification of photonic localization properties of targeted nuclear mass density variations: Application in cancer-stage detection.

Sahay P, Ganju A, Almabadi HM, Ghimire HM, Yallapu MM, Skalli O, Jaggi M, Chauhan SC, Pradhan P.

J Biophotonics. 2018 May;11(5):e201700257. doi: 10.1002/jbio.201700257. Epub 2018 Jan 17.

PMID:
29222925
5.

Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.

Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Chauhan SC, Jaggi M.

Mol Cancer Ther. 2017 Oct;16(10):2267-2280. doi: 10.1158/1535-7163.MCT-17-0157. Epub 2017 Jun 14.

6.

miRNA nanotherapeutics for cancer.

Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M.

Drug Discov Today. 2017 Feb;22(2):424-432. doi: 10.1016/j.drudis.2016.10.014. Epub 2016 Nov 1. Review.

7.

PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.

Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM.

Colloids Surf B Biointerfaces. 2016 Aug 1;144:8-20. doi: 10.1016/j.colsurfb.2016.03.071. Epub 2016 Mar 26.

8.

Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.

Khan S, Ebeling MC, Chauhan N, Thompson PA, Gara RK, Ganju A, Yallapu MM, Behrman SW, Zhao H, Zafar N, Singh MM, Jaggi M, Chauhan SC.

Cancer Res. 2015 Jun 1;75(11):2292-304. doi: 10.1158/0008-5472.CAN-14-2397. Epub 2015 Apr 3. Erratum in: Cancer Res. 2018 May 1;78(9):2444.

9.

Slit/Robo pathway: a promising therapeutic target for cancer.

Gara RK, Kumari S, Ganju A, Yallapu MM, Jaggi M, Chauhan SC.

Drug Discov Today. 2015 Jan;20(1):156-64. doi: 10.1016/j.drudis.2014.09.008. Epub 2014 Sep 20. Review.

10.

Protein kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity.

Sundram V, Ganju A, Hughes JE, Khan S, Chauhan SC, Jaggi M.

Oncotarget. 2014 Aug 30;5(16):6867-84.

11.

Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.

Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC.

Biomaterials. 2014 Oct;35(30):8635-48. doi: 10.1016/j.biomaterials.2014.06.040. Epub 2014 Jul 12.

12.

Nanoways to overcome docetaxel resistance in prostate cancer.

Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M.

Drug Resist Updat. 2014 Apr;17(1-2):13-23. doi: 10.1016/j.drup.2014.04.001. Epub 2014 Apr 5. Review.

Supplemental Content

Loading ...
Support Center